Literature DB >> 12410475

The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection.

Ming-Cheng Wang1, Chin-Chung Tseng, Chiung-Yu Chen, Jiunn-Jong Wu, Jeng-Jong Huang.   

Abstract

We studied the pathogenic role of host and Escherichia coli virulence factors in the development of E. coli bacteremia in patients with acute cholangitis (AC) or upper urinary tract infection (UTI). Isolates recovered from 75 adult patients consecutively admitted to the hospital with E. coli bacteremia caused by AC (n=24) or upper UTI (n=51) were evaluated, as were 30 fecal strains isolated from healthy control individuals. Virulence genes of E. coli were detected by polymerase chain reaction analysis, including papG genes (classes I-III), sfa/foc, fimH, afa, hlyA, cnf1, and iutA. Our results show that biliary tract obstruction and urinary tract obstruction are important host factors for the development of E. coli bacteremia in patients with AC and upper UTI, respectively. With regard to E. coli virulence factors, the papG class II gene might play a more important role in the development of E. coli bacteremia in patients with upper UTI than in those with AC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410475     DOI: 10.1086/343828

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  19 in total

Review 1.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

2.  Prevalence of Escherichia coli Carrying pks Islands in Bacteremia Patients.

Authors:  Eunyoung Lee; Yangsoon Lee
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

3.  The complex interplay among bacterial motility and virulence factors in different Escherichia coli infections.

Authors:  C Y Kao; W H Lin; C C Tseng; A B Wu; M C Wang; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-24       Impact factor: 3.267

4.  Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

Authors:  S J Drews; S M Poutanen; T Mazzulli; A J McGeer; A Sarabia; S Pong-Porter; Y Rzayev; B Willey; K Green; D E Low
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Shigella sonnei bacteraemia occurring in a young man with shigellosis.

Authors:  Andrew Huynh; Christian McGrath; Douglas Johnson; Louise M Burrell
Journal:  BMJ Case Rep       Date:  2015-04-28

6.  Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia.

Authors:  Jose A Martínez; Sara Soto; Anna Fabrega; Manel Almela; Josep Mensa; Alex Soriano; Francesc Marco; María T Jimenez de Anta; Jordi Vila
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

7.  Impact of virulence genes on sepsis severity and survival in Escherichia coli bacteremia.

Authors:  Marta Mora-Rillo; Natalia Fernández-Romero; Carolina Navarro-San Francisco; Jesús Díez-Sebastián; Maria Pilar Romero-Gómez; Francisco Arnalich Fernández; Jose Ramon Arribas López; Jesús Mingorance
Journal:  Virulence       Date:  2015       Impact factor: 5.882

8.  Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections.

Authors:  James R Johnson; Abby Gajewski; Alan J Lesse; Thomas A Russo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Escherichia coli in southern Taiwan.

Authors:  Wei-Hung Lin; Chin-Chung Tseng; An-Bang Wu; Yu-Tzu Chang; Te-Hui Kuo; Jo-Yen Chao; Ming-Cheng Wang; Jiunn-Jong Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-21       Impact factor: 3.267

10.  The pancreatic zymogen granule membrane protein, GP2, binds Escherichia coli Type 1 fimbriae.

Authors:  Su Yu; Anson W Lowe
Journal:  BMC Gastroenterol       Date:  2009-07-23       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.